Robeco Institutional Asset Management
PDLI

Robeco Institutional Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Robeco Institutional Asset Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-872,700
Closed -$2.56M – 1007
2018
Q1 		$2.56M Hold
872,700
– – 0.01% 627
2017
Q4 		$2.39M Sell
872,700
-147,100
-14% -$452K 0.01% 597
2017
Q3 		$3.46M Hold
1,019,800
– – 0.02% 499
2017
Q2 		$2.52M Hold
1,019,800
– – 0.02% 550
2017
Q1 		$2.32M Sell
1,019,800
-1,946,802
-66% -$4.31M 0.02% 555
2016
Q4 		$6.29M Sell
2,966,602
-34,104
-1% -$95.2K 0.05% 341
2016
Q3 		$10.1M Sell
3,000,706
-6,970
-0.2% -$22.1K 0.07% 268
2016
Q2 		$9.45M Sell
3,007,676
-45,576
-1% -$152K 0.07% 253
2016
Q1 		$10.2M Sell
3,053,252
-5,594
-0.2% -$17.4K 0.08% 237
2015
Q4 		$10.8M Buy
3,058,846
+600,426
+24% +$2.51M 0.09% 227
2015
Q3 		$12.4M Buy
2,458,420
+14,286
+0.6% +$81.9K 0.09% 243
2015
Q2 		$15.7M Sell
2,444,134
-158,597
-6% -$1.06M 0.12% 217
2015
Q1 		$18.3M Sell
2,602,731
-16,354
-0.6% -$118K 0.14% 204
2014
Q4 		$20.2M Buy
2,619,085
+1,056,071
+68% +$8.36M 0.14% 187
2014
Q3 		$11.7M Buy
1,563,014
+607,726
+64% +$5.64M 0.08% 236
2014
Q2 		$9.25M Buy
955,288
+2,225
+0.2% +$19.8K 0.07% 256
2014
Q1 		$7.92M Buy
953,063
+621,005
+187% +$5.32M 0.06% 263
2013
Q4 		$2.8M Buy
+332,058
New +$2.8M 0.02% 331

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Robeco Institutional Asset Management's PDLI Position: Q2 2018 in Review

Robeco Institutional Asset Management sold out of PDL BioPharma, Inc. (PDLI) in Q2 2018, closing a stake of 872,700 shares — an estimated $2.56M sold.

Robeco Institutional Asset Management first reported a position in PDLI in Q4 2013 and held it in 18 quarters. The position peaked at $20.2M in Q4 2014. 163 funds tracked by Wall St. Rank hold PDLI as of Q2 2018.

  • Robeco Institutional Asset Management reported no remaining PDL BioPharma, Inc. position as of Q2 2018 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 872,700 PDL BioPharma, Inc. shares in Q2 2018, an estimated $2.56M.
  • Robeco Institutional Asset Management first reported a position in PDL BioPharma, Inc. in Q4 2013 and held it in 18 quarters.
  • Robeco Institutional Asset Management's PDL BioPharma, Inc. position peaked at $20.2M in Q4 2014.
  • 163 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2018.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2018, filed 3 Aug 2018.